Lerner Neil

Chief Accounting OfficerCompass Therapeutics, Inc. (CMPX) · full profile →Form 4/A · filed Apr 30, 2026
Net Buying
Open-Market Buys
$28K
Open-Market Sells
$0
Net Open-Market Flow
$28K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 29, 2026Buy(P)15K$1.89$28K398K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001171843-26-002894) within minutes of acceptance. Every field above traces to the original document. Verify it directly: